Lack of Type 2 T Cell-Independent B Cell Responses and Defect in Isotype Switching in TNF-Lymphotoxin α-Deficient Mice

Journal of Immunology

Volumn 158, Issue 5, 1997, Pages 2126-2133

  Ryffel, Bernhard ^a   Di Padova, Franco ^b   Schreier, Max H ^b   Le Hir, Michel ^c   Eugster, Hans Pietro ^c   Quesniaux, Valerie F J ^b  

^a UNIVERSITY OF BASEL   (Switzerland)

^b Preclinical Research   (Switzerland)

^c ETH ZURICH   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

2,4 DINITROPHENYL ALANYLGLYCYLGLYCYL FICOLL; 2,4-DINITROPHENYL-ALANYLGLYCYLGLYCYL-FICOLL; DRUG DERIVATIVE; FICOLL; LYMPHOTOXIN; THYMUS INDEPENDENT ANTIGEN; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL; ANTIBODY PRODUCTION; ARTICLE; B LYMPHOCYTE; BONE MARROW TRANSPLANTATION; C57BL MOUSE; ERYTHROCYTE; GENE REARRANGEMENT; GENETICS; GERMINAL CENTER; IMMUNIZATION; IMMUNOLOGY; METABOLISM; MOUSE; MOUSE MUTANT; SHEEP;

ANIMALS; ANTIBODY FORMATION; ANTIGENS, T-INDEPENDENT; B-LYMPHOCYTES; BONE MARROW TRANSPLANTATION; ERYTHROCYTES; FICOLL; GERMINAL CENTER; IMMUNIZATION; IMMUNOGLOBULIN CLASS SWITCHING; LYMPHOTOXIN-ALPHA; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; SHEEP; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0031091733     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (34)

1. Aggarwal, B. B., and J. Vilcek. 1992. Tumor Necrosis Factor, Structure, Function, and Mechanism of Action. Marcel Dekker, Inc., New York.
2. Beutler, B. 1992. Tumour Necrosis Factor: The Molecules and Their Emerging Role in Medicine. Raven Press, New York.
3. Beutler, B., and C. van Huffel. 1994. Unraveling function in the TNF ligand and receptor families. Science 264:667.
4. Jacob, C. O., S. Aiso, S. A. Michie, H. O. McDevitt, and H. Acha-Orbea. 1990. Prevention of diabetes in nonobese diabetic mice by tumor necrosis factor (TNF): similarities between TNF-α and interleukin 1. Proc. Natl. Acad. Sci. USA 87:968.
5. Ruddle, N. H., C. M. Bergman, K. M. McGrath, E. G. Lingenheld, M. L. Grunnet, S. J. Padula, and R. B. Clark. 1990. An antibody to lymphotoxin and tumor necrosis factor prevents transfer of experimental allergic encephalomyelitis. J. Exp. Med. 172:1193.
6. Picarella, D. E., A. Kratz, C. B. Li, N. H. Ruddle, and R. A. Flavell. 1992. Insulitis in transgenic mice expressing tumor necrosis factor β(lymphotoxin) in the pancreas. Proc. Natl. Acad. Sci. USA 89:10036.
7. Picarella, D. E., A. Kratz, C. B. Li, N. H. Ruddle, and R. A. Flavell. 1993. Transgenic tumor necrosis factor (TNF)-α production in pancreatic islets leads to insulitis, not diabetes. Distinct patterns of inflammation in TNF-alpha and TNF-beta transgenic mice. J. Immunol. 150:4136.
8. Guerder, S., D. E. Picarella, P. S. Linsley, and R. A. Flavell. 1994. Costimulator B7-1 confers antigen-presenting-cell function to parenchimal tissue and in conjugation with tumor necrosis factor α leads to autoimmunity in transgenic mice. Proc. Natl. Acad. Sci. USA 91:5138.
9. Qin, Z., and T. Blankenstein. 1995. Tumor growth inhibition mediated by lymphotoxin: evidence of B lymphocyte involvement in the antitumor response. Cancer Res. 55:4747.
10. Androlewicz, M. J., J. L. Browning, and C. F. Ware. 1992. Lymphotoxin is expressed as a heteromeric complex with a distinct 33-kDa glycoprotein on the surface of an activated human T cell hybridoma. J. Biol. Chem. 267:2542.
11. Browning, J. L., A. Ngam-ek, P. Lawton, J. DeMarinis, R. Tizard, E. P. Chow, C. Hession, B. O'Brine-Greco, S. F. Foley, and C. F. Ware. 1993. Lymphotoxin β, a novel member of the TNF family that forms a heteromeric complex with lymphotoxin on the cell surface. Cell 72:847.
12. Crowe, P. D., T. L. VanArsdale, B. N. Walter, C. F. Ware, C. Hession, B. Ehrenfels, J. L. Browning, W. S. Din, R. G. Goodwin, and C. A. Smith. 1994. A lymphotoxin-β-specific receptor. Science 264:707.
13. Baens, M., M. Chaffanet, J. J. Cassiman, H. van-den-Berghe, and P. Marynen. 1993. Construction and evaluation of a hncDNA library of human 12p transcribed sequences derived from a somatic cell hybrid. Genomics 16:214.
14. De Togni, P., J. Goellner, N. H. Ruddle, P. R. Streeter, A. Fick, S. Mariathasan, S. C. Smith, R. Carlson, L. P. Shornick, J. Strauss-Schoenberger, J. H. Russel, R. Karr, and D. D. Chaplin. 1994. Abnormal development of peripheral lymphoid organs in mice deficient in lymphotoxin. Science 264:703.
15. Banks, T. A., B. T. Rouse, M. K. Kerley, P. J. Blair, V. L. Godfrey, N. K. Kuklin, D. M. Bouley, J. Thomas, S. Kanangat, and M. L. Mucenski. 1995. Lymphotoxin-α deficient mice. J. Immunol. 155:1685.
16. Eugster, H. P., M. Muller, U. Karrer, B. D. Car, B. Schnyder, V. M. Eng, G. Woerly, M. Le Hi, F. Di Padova, M. Aguet, R. Zinkernagel, H. Bluethman, and B. Ryffel. 1996. Multiple immune abnormalities in tumor necrosis factor and lymphotoxin-α double deficient mice. Int. Immunol. 8:23.
17. Xu, J., T. M. Foy, J. D. Laman, E. A. Elliott, J. J. Dunn, T. J. Waldschmidt, J. Elsemore, R. J. Noelle, and R. A. Flavell. 1994. Mice deficient for the CD40 ligand. Immunity 1:423.
18. Kawabe, T., T. Naka, K. Yoshida, T. Tanaka, H. Fujiwara, S. Suematsu, N. Yoshida, T. Kishimoto, and H. Kikutani. 1994. The immune responses in CD40-deficient mice: impaired immunoglobulin class switching and germinal center formation. Immunity 1:167.
19. Castigli, E., F. W. Alt, L. Davidson, A. Bottaro, E. Mizoguchi, A. K. Bhan, and R. S. Geha. 1994. CD40-deficient mice generated by recombination-activating gene-2-deficient blastocyst complementation. Proc. Natl. Acad. Sci. USA 91:12135.
20. Renshaw, B. R., W. R. Fanslow, R. J. Armitage, K. A. Campbell, D. Liggitt, B. Wright, B. L. Davison, and C. R. Maliszewski. 1994. Humoral immune responses in CD40 ligand-deficient mice. J. Exp. Med. 180:1889.
21. Matsumoto, M., S. Mariathasan, M. H. Nahm, F. Baranyay, J. J. Peschon, and D. D. Chaplin. 1996. Role of lymphotoxin and type I TNF receptor in the formation of germinal centers. Science 271:1289.
22. Inman, J. K. 1975. Thymus-independent antigens: the preparation of covalent, hapten-Ficoll conjugates. J. Immunol. 114:704.
23. Kelly, B. S., J. G. Levy, and L. Sikora. 1979. The use of the enzyme-linked immunosorbent assay (ELISA) for the detection and quantification of specific antibody from cell cultures. Immunology 37:45.
24. Ryffel, B., M. Brockhaus, U. Durmuller, and F. Gudat. 1991. Tumor necrosis factor receptors in lymphoid tissues and lymphomas: source and site of action of tumor necrosis factor α. Am. J. Pathol. 139:7.
25. Muller, M., H. P. Eugster, M. Le Hir, A. Shakhov, F. Di Padova, C. Maurer, V. F. J. Quesniaux, and B. Ryffel. 1996. Correction and transfer of immunodeficiency due to TNF-LTα deletion by bone marrow transplantation. Mol. Med. 2:247.
26. Nordin, A. A., and M. H. Schreier. 1982. T cell control of the antibody response to the T-independent antigen, DAGG-Ficoll. J. Immunol. 129:557.
27. Letvin, N. L., B. Benacerraf, and R. N. Germain. 1981. B-lymphocyte responses to trinitrophenyl-conjugated Ficoll: requirement for T-lymphocytes and Ia-bearing adherent cells. Proc. Natl. Acad. Sci. USA 78:5113.
28. Ghiara, P., D. Boraschi, L. Nencioni, P. Ghezzi, and A. Tagliabue. 1987. Enhancement of in vivo immune response by tumor necrosis factor. J. Immunol. 139:3676.
29. + T cell clones provides a costimulatory signal for human B cell activation. J. Exp. Med. 177:1575.
30. + T cell clones: role for membrane TNF-α/TNF-α receptors and CD2/CD58 interactions. J. Immunol. 153:4872.
31. Pfeffer, K., T. Matsuyama, T. M. Kundig, A. Wakeham, K. Kishihara, A. Shahinian, K. Wiegmann, P. S. Ohashi, M. Kronke, and T. W. Mak. 1993. Mice deficient for the 55 kd tumor necrosis factor receptor are resistant to endotoxic shock, yet succumb to L. monocytogenes infection. Cell 73:457.
32. Rothe, J., W. Lesslauer, H. Lotscher, Y. Lang, P. Koebel, F. Kontgen, A. Althage, R. Zinkernagel, M. Steinmetz, and H. Bluethmann. 1993. Mice lacking the tumour necrosis factor receptor 1 are resistant to TNF-mediated toxicity but highly susceptible to infection by Listeria monocytogenes. Nature 364:798.
33. Erickson, S. L., F. J. de Sauvage, K. Kikly, S. Pitts-Meek, N. Gillett, K. Sheehan, R. D. Schreiber, D. V. Goeddel, and M. W. Moore. 1994. Decreased sensitivity to tumour-necrosis factor but normal T-cell development in TNF receptor-2-deficient mice. Nature 372:560.
34. Le Hir, M., H. Bluethmann, M. Kosco-Vilbois, M. Muller, F. Di Padova, M. Moore, B. Ryffel, and H. P. Eugster. 1996. Differentiation of follicular dendritic cells and full antibody responses require tumor necrosis factor receptor-1 signalling. J. Exp. Med. 183:2367.